A detailed history of Redmile Group, LLC transactions in Insulet Corp stock. As of the latest transaction made, Redmile Group, LLC holds 27,109 shares of PODD stock, worth $8.81 Million. This represents 0.75% of its overall portfolio holdings.

Number of Shares
27,109
Previous 9,559 183.6%
Holding current value
$8.81 Million
Previous $2.5 Million 185.33%
% of portfolio
0.75%
Previous 0.2%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$237.06 - $288.29 $4.16 Million - $5.06 Million
17,550 Added 183.6%
27,109 $7.12 Million
Q4 2024

Feb 14, 2025

BUY
$227.79 - $275.7 $2.18 Million - $2.64 Million
9,559 New
9,559 $2.5 Million

Others Institutions Holding PODD

About INSULET CORP


  • Ticker PODD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 69,403,600
  • Market Cap $22.6B
  • Description
  • Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...
More about PODD
Track This Portfolio

Track Redmile Group, LLC Portfolio

Follow Redmile Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redmile Group, LLC with notifications on news.